| 31.07.2025 14:25 | WPP, WPM, SXS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 09.07.2025 09:00 | HIK | Notice of Results | RNS |
| 07.07.2025 09:16 | HIK | Publication of Offering Circular | RNS |
| 30.06.2025 10:29 | HIK | Hikma Pharmaceuticals plans USD1 billion investment to support US unit | Alliance |
| 10.06.2025 11:58 | MTO, ABDP, WISE | DIRECTOR DEALINGS: Hikma exec and AB Dynamics advisor sell shares | Alliance |
| 09.06.2025 15:33 | HIK | Director/PDMR Shareholding | RNS |
| 09.06.2025 09:36 | JET2, PAG, WIZZ | LONDON BROKER RATINGS: Aviva and Dunelm cut, M&G raised | Alliance |
| 06.06.2025 13:21 | HIK, JGGI, CER | DIRECTOR DEALINGS: Mitie and Wizz Air CEOs buy after share falls | Alliance |
| 05.06.2025 14:05 | HIK | Director/PDMR Shareholding | RNS |
| 03.06.2025 13:02 | HIK | Director/PDMR Shareholding | RNS |
| 03.06.2025 09:28 | FORT, POLR, LIO | LONDON BROKER RATINGS: Jefferies raises Hiscox, cuts Rio Tinto | Alliance |
| 29.05.2025 10:04 | HIK | IN BRIEF: Fitch follows S&P in raising Hikma Pharmaceuticals to BBB | Alliance |
| 29.05.2025 07:00 | HIK | Fitch upgrades Hikma to ‘BBB’ | RNS |
| 20.05.2025 14:49 | HIK | Director/PDMR Shareholding | RNS |
| 20.05.2025 09:55 | BHP, VIC, WISE | LONDON BROKER RATINGS: Kingfisher cut; Peel Hunt ups Oxford Nanopore | Alliance |
| 15.05.2025 12:52 | HIK | Hikma shares climb on new outlook, targets USD5 billion sales by 2030 | Alliance |
| 15.05.2025 12:00 | HIK | Medium-term Group guidance ahead of US site visit | RNS |
| 14.05.2025 09:30 | ORIT, AIBG, WIX | LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi | Alliance |
| 08.05.2025 16:35 | HIK | Director/PDMR Shareholding | RNS |
| 08.05.2025 10:48 | HIK | S&P upgrades Hikma to ‘BBB’ | RNS |
| 08.05.2025 09:08 | HIK | Hikma Pharmaceuticals agrees USD50 million settlement for Xyrem claims | Alliance |
| 08.05.2025 08:21 | HIK | Settlement agreement for Xyrem® US lawsuits | RNS |
| 30.04.2025 13:21 | HIK | Director/PDMR Shareholding | RNS |
| 24.04.2025 15:55 | HIK | Result of AGM | RNS |
| 24.04.2025 13:38 | ZTF, JDW, SHIP | UK dividends calendar - next 7 days | Alliance |
| 24.04.2025 09:58 | HIK | Hikma feels "well-positioned" despite geo-political challenges | Alliance |
| 24.04.2025 07:00 | HIK | Trading Statement | RNS |
| 10.04.2025 14:36 | HIK | Director/PDMR Shareholding | RNS |
| 10.04.2025 09:26 | BPT, PHLL, ABDN | LONDON BROKER RATINGS: Jefferies raises Hikma Pharmaceutical to 'buy' | Alliance |
| 08.04.2025 13:47 | HIK | Director/PDMR Shareholding | RNS |
| 01.04.2025 09:30 | HIK | Block listing Interim Review | RNS |
| 19.03.2025 10:10 | HIK | Annual Financial Report and Notice of AGM | RNS |
| 13.03.2025 14:40 | RICA, PPET, PCA | UK dividends calendar - next 7 days | Alliance |
| 04.03.2025 11:16 | HIK | Director/PDMR Shareholding | RNS |
| 28.02.2025 09:49 | FEVR, SWR, CRN | LONDON BROKER RATINGS: Barclays cuts WPP to 'equal weight' | Alliance |
| 27.02.2025 09:35 | BME, HMSO, DOCS | LONDON BROKER RATINGS: Rio, Barratt and Dr Martens get 'buy' ratings | Alliance |
| 26.02.2025 09:03 | HIK | Hikma Pharmaceuticals to up R&D spend to support pipeline development | Alliance |
| 26.02.2025 07:00 | HIK | Final Results | RNS |
| 19.02.2025 14:28 | SEE, RCOI, HIK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 10.02.2025 08:09 | HIK | Notice of Results | RNS |
| 23.12.2024 09:46 | HIK | Director/PDMR Shareholding | RNS |
| 10.12.2024 10:01 | AVCT, SFOR, SUPR | LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders | Alliance |
| 03.12.2024 09:38 | PSN, AHT, HIK | LONDON BROKER RATINGS: RBC raises Ashtead; Deutsche Bank cuts Currys | Alliance |
| 25.11.2024 09:41 | BHP, JET2, GAMA | LONDON BROKER RATINGS: Deutsche Bank raises JD Sports and Weir | Alliance |
| 07.11.2024 15:30 | HIK | Outcome of Audit Tender Process | RNS |
| 07.11.2024 10:59 | HIK | Hikma Pharmaceuticals reiterates full-year guidance amid strong growth | Alliance |
| 07.11.2024 07:00 | HIK | Trading Statement | RNS |
| 31.10.2024 14:52 | WIZZ, WPM, TRN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 24.10.2024 07:00 | HIK | 2024 Annual General Meeting Update Statement | RNS |
| 01.10.2024 09:45 | HIK | Block listing Interim Review | RNS |
| 24.09.2024 10:09 | HIK | Director/PDMR Shareholding | RNS |
| 13.09.2024 12:38 | EGY, STJ, SDY | UK dividends calendar - next 7 days | Alliance |
| 10.09.2024 09:09 | HIK | Hikma Pharmaceuticals completes acquisition of Xellia's FDF business | Alliance |
| 10.09.2024 07:00 | HIK | Hikma completes Xellia acquisition | RNS |
| 03.09.2024 09:43 | OCI, POLR, HTG | LONDON BROKER RATINGS: Berenberg raises Hikma Pharmaceuticals to 'buy' | Alliance |
| 13.08.2024 10:16 | HIK | IN BRIEF: Hikma executive Bassam Kanaan sells 45,000 shares | Alliance |
| 13.08.2024 09:50 | TRIG, BPT, VSVS | LONDON BROKER RATINGS: Peel Hunt cuts Spirax to 'hold' | Alliance |
| 13.08.2024 09:39 | HIK | Director/PDMR Shareholding | RNS |
| 08.08.2024 16:09 | TET, THRL, SHEL | UK dividends calendar - next 7 days | Alliance |
| 08.08.2024 11:33 | HIK | Hikma Pharmaceuticals raises guidance as first-half profit jumps 43% | Alliance |
| 08.08.2024 07:00 | HIK | Half-year Report | RNS |
| 01.08.2024 14:35 | SPX, SVS, PAGE | UK earnings, trading statements calendar - next 7 days | Alliance |
